Savaria (TSE:SIS – Get Free Report) had its price target hoisted by equities research analysts at ATB Cormark Capital Markets from C$30.00 to C$32.00 in a report issued on Friday,BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. ATB Cormark Capital Markets’ target price would indicate a potential upside of 23.74% from the company’s current price.
Several other analysts have also recently commented on the stock. Stifel Nicolaus raised their price objective on shares of Savaria from C$28.00 to C$29.00 and gave the company a “buy” rating in a research note on Friday. National Bank Financial increased their target price on shares of Savaria from C$30.00 to C$30.50 and gave the company an “outperform” rating in a report on Friday. Desjardins boosted their price target on Savaria from C$27.00 to C$32.00 and gave the stock a “buy” rating in a research note on Friday. Raymond James Financial raised their price objective on Savaria from C$27.00 to C$32.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Scotiabank boosted their target price on Savaria from C$29.00 to C$30.00 and gave the stock an “outperform” rating in a research report on Friday. Seven investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Savaria has an average rating of “Buy” and a consensus target price of C$30.93.
Get Our Latest Stock Analysis on SIS
Savaria Price Performance
Savaria (TSE:SIS – Get Free Report) last released its quarterly earnings data on Wednesday, March 4th. The company reported C$0.37 earnings per share (EPS) for the quarter. The firm had revenue of C$241.78 million during the quarter. Savaria had a return on equity of 10.24% and a net margin of 6.90%. As a group, sell-side analysts anticipate that Savaria will post 1.2048518 EPS for the current year.
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Articles
- Five stocks we like better than Savaria
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
